LSD1 Inhibitor VII, SP-2509-CAS 1423715-09-6-Calbiochem

半岛bd体育手机客户端 说明

一般描述

A cell-permeable, lysine-specific demethylase 1 (LSD1) active site-targeting phenethylidene-benzohydrazide that inhibits LSD1 activity (IC₅₀= 13 nM) in a reversible and substrate non-competitive (K_i= 34 nM) manner, while inhibiting CYP3A4 only at much higher concentrations (IC₅₀= 2.61 ?M) and displaying little or no potency towards CYP1A2/2C9/2C19/2D6. MAO-A/B, D-lactate dehydrogenase, glucose oxidase, and hERG (IC₅₀≥8.0 ?M). Shown to enhance histone H3 Lys9 dimethylation (H3K9me2) in androgen-dependent prostate cancer VCaP cultures (1 to 10 ?M) and effectively inhibits LSD1-dependent cancer growth (IC₅₀in nM = 329/SK-N-MC, 356/AN3 Ca, 429/HT29, 468/MIA PaCa-2, 489/BT-20, 612/HER218, 614/HCT 116, 637/MCF-7, 649/T-47D; 96 h).
A cell-permeable phenethylidene-benzohydrazide compound that acts as a potent, selective, reversible, and non-competitive inhibitor of Lysine-Specific Demethylase 1 (LSD1; IC₅₀= 13 nM; K_i= 31 nM). Exhibits excellent selectivity over monoamine oxidases A and B (IC₅₀>300 ?M), lactate dehydrogenase, glucose oxidase, hERG, CYP1A2, CYP2D6 (IC₅₀≥ 10 ?M), CYP2C9 (IC₅₀= 8.04 ?M) and CYP2C19 (IC₅₀= 9.76 ?M). Inhibits CYP3A4 only at >200-fold higher concentration. Reduces the proliferation of several cancer cell lines, including AN3 Ca, BT-20, MCF-7, T-47D, HT29, MIA PaCa-2 and SK-N-MC (IC₅₀= 356, 489, 637, 649, 429, 468 and 329 nM, respectively).

生化/生理作用

Cell permeable: yes
Reversible: yes
Primary Target
LSD1

包装

Packaged under inert gas

警告

Toxicity: Standard Handling (A)

重悬

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

其他说明

Fiskus, W., et al. 2014.Leukemia28,2155.
Sorna, V., et al. 2013.J. Med. Chem.56,9496.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

基本信息

半岛bd体育手机客户端 性质

安全信息